Stroke Risk Factors Symptoms
Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. Find out more about risk factors and symptoms.
Search
EHS management approach
Our comprehensive EHS framework describes our EHS management system at a corporate level consisting of four elements. Click here to find out more.
COVID-19 Material donations in Germany
Boehringer Ingelheim donates protective equipment and disinfectants to authorities and social institutions at the company's German sites during COVID-19.
Type 2 Diabetes and Risk of Viral Infections
In the current COVID-19 climate, it’s important for everyone to stay safe at home, particularly people living with conditions such as type-2 diabetes.
Webinars for clinicians on needs of vulnerable respiratory
Webinars with more than 1,000 HCPs to provide an update on prevention and treatment recommendations for vulnerable respiratory patients. Learn more here.
In France, it’s time to be(e)
How about producing honey and contributing to environmental sustainability during your work hours? Click here to read more about this story.
Protecting our pets from parasites
If you think that keeping your pets indoors will keep them safe from parasites, think again! Learn more about protecting your pets from parasites.
Stroke, Don’t Stay at Home
During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
Waste
Resource conservation at Boehringer Ingelheim is managed as part of an ongoing process of prevention and reduction of material usage and waste. Learn more.
COVID-19 USA Partnership ensures jobs & feeds community
Boehringer Ingelheim & partners feed the hungry, first responders and manufacturing employees still working onsite. Click here to learn more.
COVID-19 PetPro Connect
Our PetPro Connect platform connects veterinarians and pet owners and makes it easy to deliver the collaborative pet care experience pet owners seek.
Patient Safety
Patient Safety@ Boehringer Ingelheim Pharmacovigilance
COVID-19 Q&A for Patients
Corona and COVID-19 can lead to many questions. We want to answer a few of them, provide some general information and give some recommendations.
3 things you should know about avian influenza
Poultry farming communities across the globe are grappling once again with avian influenza. Click here to find out three things you should know about it.
Marek's Disease Poultry Chicken
Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems. Learn more here.
Global poultry trends Professor David Hughes
Professor David Hughes takes us through megatrends in poultry. Poultry is booming – sustainably and in the long-term. Click here to read more.
Stroke Prevention in AF
Click here for more information on Stroke Prevention in Atrial Fibrillation
The Supplier Code of Conduct
Read about Boehringer Ingelheim's expectations towards its suppliers on ethical behaviour, integrity, professionalism and common business requirements.
More Green Overview
Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects. Click here to find out more information and learn more.
COVID-19 In Colombia we support integrally
At Boehringer Ingelheim Colombia, we are caring for those in the most vulnerable situations during COVID-19. Click here to learn more about our work.
COVID-19 IMI2–Call 21
CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.
Living Independence
Boehringer Ingelheim’s corporate culture is based on values that have been applied since the company was founded in 1885. Click here to learn more.
Bees and biodiversity
At Boehringer Ingelheim we attach great importance to sustainable planting on our company site – and to protecting the bees. Click here to find out more.
Patient Organizations
Boehringer Ingelheim’s core principles and vision guide our work with patient organisations. Learn about how we collaborate with patient organisations.
1948-1988
Following the death of Albert Boehringer (1861-1939), his two sons and his son-in-law Julius Liebrecht took over this family company. Learn more.